P53-directed translational control can shape and expand the universe of p53 target genes

Cell Death and Differentiation

Volumn 21, Issue 10, 2014, Pages 1522-1534

  Zaccara, S ^a   Tebaldi, T ^a   Pederiva, C ^a   Ciribilli, Y ^a   Bisio, A ^a   Inga, A ^a  

^a UNIVERSITY OF TRENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CPEB4 PROTEIN, HUMAN; DDX17 PROTEIN, HUMAN; DEAD BOX PROTEIN; DNA; DNA BINDING PROTEIN; DOXORUBICIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNP D0; IMIDAZOLE DERIVATIVE; MESSENGER RNA; NUCLEAR PROTEIN; NUTLIN 3; PIPERAZINE DERIVATIVE; PROTEIN P53; PROTEIN TDP-43; RNA; RNA BINDING PROTEIN; SERINE-ARGININE-RICH SPLICING PROTEINS; SMALL INTERFERING RNA; Y BOX BINDING PROTEIN 1; YBX1 PROTEIN, HUMAN;

APOPTOSIS; BIOSYNTHESIS; CELL CYCLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; RNA TRANSLATION; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DNA; DNA-BINDING PROTEINS; DOXORUBICIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HUMANS; IMIDAZOLES; MCF-7 CELLS; NUCLEAR PROTEINS; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; PIPERAZINES; RNA; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; Y-BOX-BINDING PROTEIN 1;

EID: 84930513716     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.79     Document Type: Article

References (61)

1. Levine aJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 2006; 13: 1027-1036.
2. Lion M, Bisio A, Tebaldi T, De Sanctis V, Menendez D, Resnick M.A et al. Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. Cell Cycle 2013; 12: 1211-1224.
3. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731-745.
4. Hinnebusch AG, Lorsch J.R. The mechanism of eukaryotic translation initiation: new insights and challenges. Cold Spring Harb Perspect Biol 2012; 4: a011544.
5. Dever TE, Green R. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb Perspect Biol 2012; 4: a013706.
6. Glisovic T, Bachorik JL, Yong J, Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 2008; 582: 1977-1986.
7. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
8. Provenzani A, Fronza R, Loreni F, Pascale A, Amadio M, Quattrone A. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 2006; 27: 1323-1333.
9. Tebaldi T, Re A, Viero G, Pegoretti I, Passerini A, Blanzieri E et al. Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells. BMC Genomics 2012; 13: 220.
10. Le MTN, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009 862-876.
11. Chen J, Kastan MB. 50-30-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev 2010; 24: 2146-2156.
12. Freeman Ja, Espinosa JM. The impact of post-transcriptional regulation in the p53 network. Brief Funct Genomics 2013; 12: 46-57.
13. Scoumanne A, Cho SJ, Zhang J, Chen X. The cyclin-dependent kinase inhibitor p21 is regulated by RNA-binding protein PCBP4 via mRNA stability. Nucleic Acids Res 2011; 39: 213-224.
14. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y et al. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 2000; 20: 760-769.
15. Ghosh M, Aguila HL, Michaud J, Ai Y, Wu MT, Hemmes A et al. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J Clin Invest 2009; 119: 3530-3543.
16. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009; 460: 529-533.
17. Zhang J, Cho SJ, Chen X. RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability. Proc Natl Acad Sci USA 2010; 107: 1-6. www.pnas.org/cgi/doi/10.1073/pnas.0912594107.
18. Rahman-roblick R, Roblick UJ, Hellman U, Conrotto P, Liu T, Becker S et al. p53 targets identified by protein expression profiling. Proc Natl Acad Sci USA 2007; 104: 5401-5406.
19. Arava Y. Isolation of polysomal RNA for microarray analysis. Methods Mol Biol 2003; 224: 79-87.
20. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
21. Melamed D, Eliyahu E, Arava Y, Bä hler J. Exploring translation regulation by global analysis of ribosomal association. Methods 2009; 48: 301-305.
22. Ek P, Pettersson G, Ek B, Gong F, Li JP, Zetterqvist O. Identification and characterization of a mammalian 14-kDa phosphohistidine phosphatase. Eur J Biochem 2002; 269: 5016-5023.
23. Peterson D, Lee J, Lei XC, Forrest WF, Davis DP, Jackson PK et al. A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress. Cancer Res 2010; 70: 6325-6335.
24. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402-412.
25. Andrysik Z, Kim J, Tan AC, Espinosa JM. A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation. Cell Rep 2013; 3: 1346-1354.
26. Sax JK, El-Deiry WS. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. J Biol Chem 2003; 278: 36435-36444.
27. Salvador JM, Brown-Clay JD, Fornace AJ. Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol 2013; 793: 1-19.
28. Nikulenkov F, Spinnler C, Li H, Tonelli C, Shi Y, Turunen M et al. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Differ 2012; 19: 1992-2002.
29. Xu K, Chen Z, Qin C, Song X. miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. Onco Targets Ther 2014; 7: 325-332.
30. Fregoso OI, Das S, Akerman M, Krainer AR. Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. Mol Cell 2013; 50: 56-66.
31. Tian B, Liu J, Liu B, Dong Y, Liu J, Song Y et al. p53 suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line. J Cell Physiol 2011; 226: 3433-3441.
32. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485: 109-113.
33. Feng Z. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol 2010; 2: a001057.
34. Zhu X, Li Y, Shen H, Li H, Long L, Hui L et al. miR-137 restoration sensitizes multidrugresistant MCF-7/ADM cells to anticancer agents by targeting YB-1. Acta Biochim Biophys Sin (Shanghai) 2013; 45: 80-86.
35. Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013; 153: 654-665.
36. Das S, Anczuków O, Akerman M, Krainer AR. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Cell Rep 2012; 1: 110-117.
37. Lasham A, Samuel W, Cao H, Patel R, Mehta R, Stern JL et al. YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst 2012; 104: 133-146.
38. MunõzÚ , Puche JE, Hannivoort R, Lang UE, Cohen-Naftaly M, Friedman SL. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1. Mol Cancer Res 2012; 10: 1216-1227.
39. Weidensdorfer D, Stö hr N, Baude A, Lederer M, Köhn M, Schierhorn A et al. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 2009; 15: 104-115.
40. Bugaut A, Balasubramanian S. 50-UTR RNA G-quadruplexes: translation regulation and targeting. Nucleic Acids Res 2012; 40: 4727-4741.
41. Pichon X, Wilson LA, Stoneley M, Bastide A, King HA, Somers J et al. RNA binding protein/RNA element interactions and the control of translation. Curr Protein Pept Sci 2012; 13: 294-304.
42. Dassi E, Re A, Leo S, Tebaldi T, Pasini L, Peroni D et al. AURA 2: empowering discovery of post-transcriptional networks. Translation 2014; 2: e27738.
43. Menendez D, Nguyen TA, Freudenberg JM, Mathew VJ, Anderson CW, Jothi R et al. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res 2013; 41: 7286-7301.
44. Nicholson J, Neelagandan K, Huart AS, Ball K, Molloy MP, Hupp T. An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand nutlin-3 on cellular proteostasis. J Proteome Res 2012; 11: 5464-5478.
45. Mazan-Mamczarz K, Hagner PR, Dai B, Wood WH, Zhang Y, Becker KG et al. Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. Cancer Res 2008; 68: 7730-7735.
46. Fernández-Miranda G, Méndez R. The CPEB-family of proteins, translational control in senescence and cancer. Ageing Res Rev 2012; 11: 460-472.
47. Novoa I, Gallego J, Ferreira PG, Mendez R. Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control. Nat Cell Biol 2010; 12: 447-456.
48. Fuller-Pace FV, Nicol SM. DEAD-box RNA helicases as transcription cofactors. Methods Enzymol 2012; 511: 347-367.
49. Das S, Fregoso OI, Krainer AR. A new path to oncogene-induced senescence: at the crossroads of splicing and translation. Cell Cycle 2013; 12: 1477-1479.
50. Leaõ M, Gomes S, Soares J, Bessa C, Maciel C, Ciribilli Y et al. Novel simplified yeastbased assays of regulators of p53-MDMX interaction and p53 transcriptional activity. FEBS J 2013; 280: 6498-6507.
51. Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonzà lez E et al. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 2013; 24: 318-330.
52. Loayza-Puch F, Drost J, Rooijers K, Lopes R, Elkon R, Agami R. p53 induces transcriptional and translational programs to suppress cell proliferation and growth. Genome Biol 2013; 14: R32.
53. Bisio A, Nasti S, Jordan JJ, Gargiulo S, Pastorino L, Provenzani A et al. Functional analysis of CDKN2A/p16INK4a 50-UTR variants predisposing to melanoma. Hum Mol Genet 2010; 19: 1479-1491.
54. Tebaldi T, Dessi E, Kostoska G, Viero G, Quattrone A. tRanslatome: an R/Bioconductor package to portrait translational control. Bioinformatics 2014; 30: 289-291.
55. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
56. Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C et al. Insights into RNA biology from an Atlas of mammalian mRNA-binding proteins. Cell 2012; 149: 1393-1406.
57. Baltz AG, Munschauer M, Schwanhaüsser B, Vasile A, Murakawa Y, Schueler M et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell 2012; 46: 674-690.
58. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611-622.
59. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 2009; 284: 8023-8032.
60. Denti M.A, Rosa A, Sthandier O, De Angelis FG, Bozzoni I. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 2004; 10: 191-199.
61. Ciribilli Y, Monti P, Bisio A, Nguyen HT, Ethayathulla AS, Ramos A et al. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic Acids Res 2013; 41: 8637-8653.